China Sihuan Subsidiary To Buy Dupromise For $361 Million
This article was originally published in PharmAsia News
Executive Summary
China's Sihuan Pharmaceutical said its Sun Moral Internatioinal subsidiary plans to take over Dupromise Holdings for $361 million